Results 11 to 20 of about 10,310,741 (229)

Rosai-Dorfman Disease, Presenting as a Mass in the Trachea: A Case Report. [PDF]

Respirol Case Rep
We present a rare case of Rosai–Dorfman disease (RDD) confined solely to the trachea. After initial bronchoscopic resection, systemic corticosteroid therapy was initiated due to lesion progression, successfully stabilizing the disease for 4 years. ABSTRACT A 45‐year‐old woman was referred to our clinic for evaluation of a 17 mm tracheal mass detected ...
Youn T, Lee B, Han J, Jeong BH.
europepmc   +2 more sources

Intrathoracic Rosai-Dorfman Disease in Elderly Patients: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Rosai–Dorfman disease (RDD), a rare form of histiocytosis, predominantly affects young individuals. Clinically categorized into nodal and extranodal subtypes, the disease primarily involves systemic lymph nodes with possible involvement of other organs.
Xiao J, Ma L, Cao W.
europepmc   +2 more sources

A Single Case of Rosai–Dorfman Disease Marked by Pathologic Fractures, Kidney Failure, and Liver Cirrhosis Treated with Single-Agent Cladribine [PDF]

Frontiers in Oncology, 2014
Rosai-Dorfman disease (RDD) is a proliferative histiocytic disorder of unknown etiology, which is characterized by sinus histiocytosis with massive lymphadenopathy (1). In most cases, RDD has a benign course and treatment is not necessary. However, severe cases of RDD require treatment, and the treatment strategy is determined on the basis of the ...
Sasaki, Koji, Pemmaraju, Naveen, Westin, Jason R., Wang, Wei-Lien, Khoury, Joseph D., Podoloff, Donald A., Moon, Bryan, Daver, Naval, Borthakur, Gautam   +8 more
openaire   +3 more sources

Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.

JAMA Oncology, 2022
Importance Rosai-Dorfman disease (RDD) is a rare histiocytic neoplasm with recent studies showing alterations in the MAPK pathway, most commonly in the KRAS and MEK genes in about 40% of patients.
J. Abeykoon, K. Rech, J. Young, A. Ravindran, G. Ruan, S. Dasari, D. Morlote, R. King, Claire Rummage, S. Zanwar, Aldo M Acosta-Medina, W. Tobin, M. Shah, N. Bennani, R. Vassallo, J. Ryu, M. Koster, Caroline Davidge-Pitts, T. Witzig, G. Goyal, R. Go   +20 more
semanticscholar   +1 more source

Emergence of cutaneous Rosai–Dorfman disease during immunosuppressive treatment of follicular B-cell lymphoma: A case report

SAGE Open Medical Case Reports, 2021
Background: Sinus histiocytosis with massive lymphadenopathy, also known as Rosai–Dorfman disease, is a rare proliferation of non-Langerhans histiocytes.
Sharon L Kipfer, Michael Samycia, Carolyn J Shiau   +2 more
doaj   +1 more source

Rosai-Dorfman disease: an overview

Journal of Clinical Pathology, 2020
Context Rosai-Dorfman disease is an uncommon histiocytic disorder most frequently presenting as bilateral cervical lymphadenopathy in children and young adults. Extranodal disease occurs in a significant proportion of patients.
C. Bruce-Brand, J. Schneider, P. Schubert   +2 more
semanticscholar   +1 more source

Revisiting Rosai Dorfman disease: A rare histiocytic disorder with nodal and extranodal involvement

South African Journal of Radiology, 2023
Rosai Dorfman disease is a rare but benign and self-limiting disorder. A case of Rosai Dorfman disease in a 16-year-old female with classic radiological and pathological findings is presented.
Smily Sharma, Poonam Sherwani, Venkata S. Arunachalam, Rahul Dev   +3 more
doaj   +1 more source

Histological variability and the importance of clinicopathological correlation in cutaneous Rosai-Dorfman disease [PDF]

Anais Brasileiros de Dermatologia, 2016
: Rosai-Dorfman disease is a benign histiocytic proliferative disorder of unknown etiology. The disease mainly affects lymph node tissue, although it is rarely confined to the skin.
Ana Gameiro, Miguel Gouveia, José Carlos Cardoso, Oscar Tellechea   +3 more
doaj   +1 more source

Rosai–Dorfman disease of the central nervous system: A clinical, radiological, and prognostic study of 12 cases

Frontiers in Oncology, 2022
Background Rosai–Dorfman disease (RDD) is a rare benign non-Langerhans cell histiocytic proliferative disease. RDD with central nervous system (CNS) involvement (CNS-RDD) is extremely rare.
Xingshuo Zhang, W. Yin, Youwei Guo, Yi-duo He, Zhipeng Jiang, Yuzhe Li, Bo Xie, Sen Zhang, Xingjun Jiang, Qing Liu, Jian Yuan   +10 more
semanticscholar   +1 more source

Systemic and Craniospinal Rosai Dorfman Disease with Intraparenchymal, Intramedullary and Leptomeningeal Disease

International Journal of Hematology-Oncology and Stem Cell Research, 2021
Rosai Dorfman disease is a rare histiocytic disorder of over-production of non-Langerhans histiocytes, which typically manifests with massive lymphadenopathy and sinonasal involvement.
Yi Li, Emily Sloan, Andrew Bollen, David Solomon, Philip Theodosopoulos, Soonmee Cha   +5 more
doaj   +1 more source